| Jessica Williams Vincent, MD | |
|
901 Leighton Ave, Anniston, AL 36207-5700 | |
| (256) 236-1303 | |
| (256) 236-1386 |
| Full Name | Jessica Williams Vincent |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 19 Years |
| Location | 901 Leighton Ave, Anniston, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124255591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD.30714 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Health Care Authority Of The City Of Anniston | 3971408923 | 24 |
News Archive
A common consequence of chronically high alcohol consumption is a decline in cognitive function, which can even progress to full-blown dementia. However, we do not yet fully understand how alcohol damages the brain.
Columbia Psychiatry faculty in partnership with avoMD a next-gen clinical decision support platform, have developed an interactive smartphone application that provides point-of-care treatment algorithms for major depression.
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
As many software companies work to create programs that will give uniform structure to the way radiological test results are reported, a new study by researchers at Wake Forest University School of Medicine shows that such a system does not improve, but rather decreases the completeness and accuracy of the reports.
› Verified 5 days ago
| Entity Name | The Health Care Authority Of The City Of Anniston |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003996000 PECOS PAC ID: 3971408923 Enrollment ID: O20031203000272 |
News Archive
A common consequence of chronically high alcohol consumption is a decline in cognitive function, which can even progress to full-blown dementia. However, we do not yet fully understand how alcohol damages the brain.
Columbia Psychiatry faculty in partnership with avoMD a next-gen clinical decision support platform, have developed an interactive smartphone application that provides point-of-care treatment algorithms for major depression.
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
As many software companies work to create programs that will give uniform structure to the way radiological test results are reported, a new study by researchers at Wake Forest University School of Medicine shows that such a system does not improve, but rather decreases the completeness and accuracy of the reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Williams Vincent, MD 901 Leighton Ave, Anniston, AL 36207-5700 Ph: (256) 236-1303 | Jessica Williams Vincent, MD 901 Leighton Ave, Anniston, AL 36207-5700 Ph: (256) 236-1303 |
News Archive
A common consequence of chronically high alcohol consumption is a decline in cognitive function, which can even progress to full-blown dementia. However, we do not yet fully understand how alcohol damages the brain.
Columbia Psychiatry faculty in partnership with avoMD a next-gen clinical decision support platform, have developed an interactive smartphone application that provides point-of-care treatment algorithms for major depression.
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
As many software companies work to create programs that will give uniform structure to the way radiological test results are reported, a new study by researchers at Wake Forest University School of Medicine shows that such a system does not improve, but rather decreases the completeness and accuracy of the reports.
› Verified 5 days ago
Anthony Esposito, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1130 Leighton Ave, Anniston, AL 36201 Phone: 256-231-0022 Fax: 256-231-2266 | |
Sharman Ringland Sanders, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 901 Leighton Ave, Suite 402, Anniston, AL 36207 Phone: 256-236-1303 Fax: 256-236-1386 | |
Dr. Clarence Eugene Mcdanal Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 331 East 8th St, Anniston, AL 36207 Phone: 256-236-3403 Fax: 256-238-6263 | |
Dr. Glenn O Archibald, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1302 Noble St, Ste. 3d, Anniston, AL 36201 Phone: 256-546-9265 Fax: 256-549-0376 | |
Chandra K Gehi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1130 Leighton Ave, Anniston, AL 36207 Phone: 256-231-0022 Fax: 256-231-2266 | |
Pablo Valle-blacio, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1101 Christine Ave, Anniston, AL 36207 Phone: 256-235-0717 Fax: 256-235-0719 |